HF 3664
  • Introduced
    Feb 13, 2024
  • Passed House
  • Passed Senate
  • Became Law
HF 3664
Minnesota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.
Last Action See all actions
House • Mar 18, 2024: Author added Hemmingsen-Jaeger
Latest Bill Text See all bill texts
Introduction

Summary

Comments on HF 3664

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Mar 18, 2024 | House
    • Author added Hemmingsen-Jaeger
  • Mar 13, 2024 | House
    • Author added Nadeau
  • Feb 26, 2024 | House
    • Author added Reyer
  • Feb 13, 2024 | House
    • Introduction and first reading, referred to Health Finance and Policy
Bill Texts
Documents
Looks like we don't have any documents available at this moment.
Sources